Updated: Oct 20
Medically reviewed by ChinaCureLink Team
Table of Content
Introduction
Patients researching EBV infection may encounter Single-Cell Vaccine Therapy as an emerging cancer-immunotherapy approach. In China, this therapy is available through the Boao Lecheng medical-access pathway in Hainan. This guide explains what the treatment is, how EBV cancer vaccine China access works, who may be considered, its estimated cost, and what international patients should know before pursuing it.
Key Takeaways |
|
What Is Single-Cell Vaccine Therapy for EBV Infection?
Single-Cell Vaccine Therapy uses an antigen-specific T-cell vaccine approach designed to activate and amplify T cells that target EBV antigens.
The method involves activating or expanding EBV-targeting immune cells in vitro and then reinfusing them into the patient. Treatment is administered in multiple doses rather than as a single administration. The planned course is five sessions, with each session priced at RMB 16,000.
The approach is based on an active-immunization concept, using immune cells directed toward EBV antigens. The treatment should be evaluated separately from established EBV management, and availability through a medical-access pathway does not by itself establish clinical effectiveness.
Is EBV Cancer Vaccine China Treatment Available?
Yes. EBV cancer vaccine China access is available through the Boao Lecheng medical-access pathway in Hainan for this specific project.
Single-Cell Vaccine Therapy is included in the 3rd batch of approved Boao Lecheng projects, with a registration date of 2025 and a stated regulatory risk level of low. This pathway allows designated medical projects to be provided within the Hainan Boao Lecheng International Medical Tourism Pilot Zone following the applicable review and supervision process.
The project should not be interpreted as nationwide approval or general availability throughout mainland China. International patients must still undergo medical assessment before treatment.
Where Is EBV Cancer Vaccine China Treatment Offered?
The treatment is offered at Hainan Haikong Le City Hospital (West China Le City Hospital of Sichuan University) in Hainan.
Technical support is provided by Chengdu Zhenyu Biotechnology Co., Ltd.
Who May Be Eligible for EBV Cancer Vaccine China Treatment?
Individuals with EBV-related disease may be considered when laboratory markers indicate EBV activity, including EBV-DNA levels above 50 copies/mL. Symptomatic patients are particularly identified as potential candidates.
Suitability is assessed through a face-to-face consultation, taking the patient's medical records and clinical circumstances into account.
Final eligibility is determined by the treating medical team after a face-to-face consultation and review of the patient's medical records.
How Much Does EBV Cancer Vaccine China Treatment Cost?
The estimated cost is RMB 16,000 (approximately US$2,220) per session, with five sessions planned for a total estimated course cost of RMB 80,000 (approximately US$11,110). The USD figures use a reference exchange rate of about RMB 7.2 per US$1.
The quoted treatment price does not necessarily include consultation, diagnostic testing, hospitalization, translation or coordination services, medication, or international travel. Patients should confirm the full scope of the treatment package and final pricing directly with the hospital before making travel arrangements.
Why International Patients May Consider EBV Cancer Vaccine China Access
For some international patients, the availability of a specialized EBV-directed immunotherapy through a supervised medical-access pathway may provide another option to discuss with qualified specialists.
The Boao Lecheng pathway is particularly relevant to patients researching treatments that may not be routinely accessible in their home healthcare system. However, the existence of an approved pilot-zone project does not establish that the therapy is superior to other approaches or that it will produce a particular outcome.
Patients can use specialist consultation to understand the proposed treatment, eligibility requirements, potential benefits and risks, alternatives, and practical requirements before deciding whether to travel.
How ChinaCureLink Can Help Patients Access This Treatment
We help international patients explore available treatment options and facilitate communication with appropriate medical specialists. Patients should discuss potential benefits, risks, eligibility, and alternatives directly with qualified physicians. ChinaCureLink does not represent or endorse the treatment technology, manufacturer, or hospital.
Case review: We collect relevant medical history and EBV infection-management records to help determine whether a case is appropriate for physician review.
Hospital coordination: We help connect patients with the treating team at Hainan Haikong Le City Hospital (West China Le City Hospital of Sichuan University) in China for an initial assessment.
Online consultation before travel: Patients can discuss potential eligibility, the procedure, and expected next steps with the medical team remotely before committing to international travel.
Coordination support: Depending on the case, this can include translation assistance, appointment scheduling, and logistics coordination.
Considering EBV Cancer Vaccine China Treatment?
Before planning travel, speak with a qualified specialist to determine whether the treatment is appropriate for your condition and whether you meet the medical eligibility requirements. ChinaCureLink can help international patients arrange a specialist review and explore the treatment pathway in China. [Request a Medical Review / Speak With a Specialist]
Get a Second Opinion Before Fly to China
For suitable cases, ChinaCureLink can then coordinate an online consultation with the specialist to discuss the technical treatment details directly. The purpose is to help the patient understand which treatment option and which specialist center may be most appropriate before making an international treatment decision.
What Patients Say About ChinaCureLink & Medebound HEALTH
China CureLink operates under Medebound HEALTH — an internationally recognized healthcare navigation company incorporated in New York, with operations across North America and Asia-Pacific.
Rated 4.6 ⭐⭐⭐⭐⭐ at Trustpilot
Medebound HEALTH's online testimonials. Learn More
★★★★☆ Sarah Zhang · Canada· Jul 2024 · Verified “The interpreter during the video call was fantastic — super professional and answered all our questions clearly and quickly. The professor was also very patient and gave us detailed and honest guidance on our treatment options.” |
★★★★★ Andrew Goh · Singapore · Aug 2024 · Verified “My first contact with Medebound was over a year ago. Jason has always been responsive, even when I wasn't ready to proceed. When I finally did, the consultation was seamlessly arranged and the specialist was outstanding.” |
★★★★★ Daniel Wong · Singapore · Aug 2024 · Verified “I have dry eye and nothing seemed to be working, even with different medications. I heard about a medication from the U.S. that’s supposed to be really effective, but I didn’t want to try it without talking to a doctor first. MEDEBOUND connected me with a top ophthalmologist in the U.S. and it was so reassuring to get their expert advice.” |
★★★★☆ Pongsakorn · Thailand · Feb 2025 · Verified “Kiki at Medebound is amazing — so professional and helpful! They got my video consultation with an MD Anderson expert set up super fast, within just 5 working days. I am so grateful for their support.” |
Frequently Asked Questions
Is EBV cancer vaccine treatment available in China?
Yes. Single-Cell Vaccine Therapy for EBV-related disease is available through the Boao Lecheng pathway at Hainan Haikong Le City Hospital. This pilot-zone access does not represent nationwide approval.
How much does EBV cancer vaccine treatment cost in China?
The estimated price is RMB 16,000 (approximately US$2,220) per session, with five sessions totaling RMB 80,000 (approximately US$11,110). Confirm final pricing and what is included with the hospital.
Who may qualify for EBV cancer vaccine treatment in China?
Individuals with EBV-related disease and laboratory evidence such as EBV-DNA >50 copies/mL may be considered, particularly when symptoms are present. Final eligibility requires medical assessment by the treating team.
Can international patients receive EBV cancer vaccine treatment in China?
International patients may explore the treatment through the designated hospital and Boao Lecheng pathway, subject to medical evaluation and eligibility approval.
About ChinaCureLink
ChinaCureLink helps patients across the world access the best cancer treatment at China's top hospitals, without the delays, language barriers, and administrative confusion that typically come with seeking care abroad.
We connect patients directly with China's top cancer hospitals, ensuring that from the first case submission through to treatment and follow-up, every step is guided, translated, and coordinated by a team experienced in cross-border patient care.
ChinaCureLink is proudly affiliated with Medebound HEALTH — founded by US physicians, with over 10 years of experience and more than 3,000 patients served worldwide, Medebound HEALTH is recognized by Forbes and it is one of the most trusted patient cross-border concierge service company across North America and the Asia Pacific.
Disclaimer
This article is for informational purposes only and is not medical or financial advice. Treatment eligibility, protocols, and costs vary by individual case — confirm specifics with a coordinator and treating physician before making any decisions.
